Group 1: Financial Performance - In 2024, the company's operating revenue was 81.61 million yuan, and in Q1 2025, it reached 73.38 million yuan, representing a 134.74% increase year-on-year [8] - The net profit attributable to shareholders in Q1 2025 was 18.58 million yuan [8] - As of May 9, 2025, the total number of shareholders was 6,000 [5] Group 2: Business Strategy and Market Expansion - The company is actively expanding into overseas markets, focusing on Southeast Asia, South Asia, Africa, and Europe, leveraging local advantages to meet industrial wastewater treatment demands [3] - The management emphasizes a dual strategy of "vertical deepening and horizontal expansion" to enhance market share and develop new customer bases [7] - The company plans to continue its focus on core business development and will not pursue acquisitions of salt lake resources at this time [5] Group 3: Investor Relations and Shareholder Confidence - The management has not received any plans for share buybacks or significant shareholding reductions from executives [4][8] - The company is committed to enhancing shareholder value through improved operational performance and effective communication with investors [5] - The management will consider various factors when determining future dividend distributions, adhering to legal and regulatory requirements [6] Group 4: Future Outlook and Growth Potential - The company has signed contracts worth approximately 233.89 million yuan, which are yet to be fulfilled, indicating potential future revenue [9] - The management expresses confidence in achieving over 100 million yuan in revenue for 2025, contingent on ongoing business expansion efforts [9] - The company is focused on enhancing its core competencies in membrane separation technology and plans to invest in R&D to drive innovation [6]
*ST凯鑫(300899) - 300899*ST凯鑫投资者关系管理信息20250514